Davis Andrew
SEC CIK 1932525 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | SVP, Chief Business Off | 284.7K | — | $493.3K | 10 | 2022-11-21 | 2024-11-18 |
Most active insiders at IRWD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DENNER ALEXANDER J | Dir, 10% | — | $20.53M |
| 2 | Silver Ronald | Principal Accounting Off | — | $831.2K |
| 3 | MCCOURT Thomas A | CEO, Dir | — | $739.9K |
| 4 | John Minardo | CLO | — | $136.2K |
| 5 | Gaskins Tammi L | Chief Commercial Off | — | $100.3K |
| 6 | Martini Gregory S. | CFO | — | $81.9K |
| 7 | McHugh Julie | Dir | — | $80.5K |
| 8 | Silber Jeffrey | SVP, CMO, Head-Res, Drug | — | — |
| 9 | Moukheibir Catherine | Dir | — | — |
| 10 | Duane Jon R | Dir | — | — |
Davis Andrew made no open-market trades at IRWD in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | 2024-11-18 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $4.08 | -5,360 | 284.7K | -2% | -$21.9K | |
| 2024-05-22 | 2024-05-20 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $6.45 | -22.7K | 288.0K | -7% | -$146.6K | |
| D | 2024-03-12 | 2024-03-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | M - OptEx | $0.00 | +37.1K | 310.8K | +14% | $0 |
| D | 2024-02-14 | 2024-02-12 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $15.24 | -9,846 | 208.3K | -5% | -$150.1K |
| D | 2024-02-14 | 2024-02-12 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | A - Grant | $0.00 | +65.3K | 273.6K | +31% | $0 |
| 2023-11-22 | 2023-11-20 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $9.69 | -3,287 | 217.4K | -1% | -$31.9K | |
| 2023-05-24 | 2023-05-22 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $10.12 | -6,305 | 219.3K | -3% | -$63.8K | |
| D | 2023-03-10 | 2023-03-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | A - Grant | $0.00 | +74.2K | 225.6K | +49% | $0 |
| M | 2023-03-01 | 2023-02-27+ | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $11.36 | -3,573 | 151.4K | -2% | -$40.6K |
| 2022-11-23 | 2022-11-21 | IRWD | IRONWOOD PHARMACEUTICALS INC | Davis Andrew | SVP, Chief Business Off | S - Sale | $11.56 | -3,335 | 154.2K | -2% | -$38.6K |
Purchase Sale Sale after option exercise All abbreviations